reiteration

Ignite It
1 min read • August 12, 2024

Needham Reiterates Hold on Cannabist Holdings

Ignite It
1 min read • August 6, 2024

Needham Reiterates Buy on Trulieve Cannabis, Maintains $14.5 Price Target

Ignite It
3 min read • December 16, 2022

Profitability For Canopy And Cronos Is Elusive, Plus Cannabis Headwinds In 2023

Ignite It
3 min read • October 8, 2022

Tilray Stock Soars Then Returns To Earth On Biden’s Cannabis Pardon News, This Analyst Remains Neutral

Ignite It
2 min read • May 5, 2022

This Weedmaps Analyst Sees These ‘Tailwinds’ For Cannabis Tech Provider After Q1 Earnings

Ignite It
3 min read • May 5, 2022

Green Thumb Industries Analyst On Q1 Earnings: Cannabis Grower Has Enough Cash To Fuel Growth

Ignite It
1 min read • July 23, 2021

UPDATE: Cantor Fitzgerald on Trulieve Cannabis Overweight: Pending Acquisition Of Harvest Health & Recreation Would Expand Co. Footprint To Eight States With 126 Dispensaries And 22 Cultivation Facilities As Firm Sees Retail Leadership On A Proforma Basis

Ignite It
1 min read • June 25, 2021

UPDATE: Roth Capital On iPower: Firm Believes Accelerating Do-It-Yourself Hobbyist Cannabis Growing Backed By Legislation Environment Coupled With ‘Increasingly Robust Hydroponic Demand’ Point To Sustainable Growth Trends In Craft & Gardening

Ignite It
2 min read • April 22, 2021

Why This Organigram Analyst Says It’s A Good Time To Buy Cannabis Stock

Ignite It
2 min read • March 18, 2021

Sundial Analyst: Cannabis Stock In A ‘Transition Phase’ Due To M&A Potential, Cost-Cutting Efforts

Ignite It
2 min read • March 10, 2021

Auxly Analyst: Cannabis Stock Is ‘Flying Under The Radar’

Ignite It
2 min read • March 4, 2021

Analyst Previews Curaleaf Earnings: ‘Bellwether Of The U.S. Cannabis Industry’

Browse By Channels

 After-Hours Center
 Analyst Color
 Analyst Ratings
 Andy Barr
 Asia
 Asset Sales
 Be Your Own Boss
 Binary Options
 Biotech
 Bonds
 Broad U.S. Equity ETFs
 Buybacks
 california cannabis
 Cannabis
 cannabis earnings
 cannabis farms
 cannabis study
 Christopher Dillis
 CNBC
 Commodities
 Congress cannabis
 Congress hemp
 Contracts
 Crowdsourcing
 Cryptocurrency
 Currency ETFs
 Dividends
 Downgrades
 Earnings
 Earnings Beats
 Earnings Misses
 Econ #s
 Economics
 Education
 Emerging Market ETFs
 Emerging Markets
 Entertainment
 Entrepreneurship
 Equities
 ESG
 ETFs
 Eurozone
 Events
 Exclusives
 Fast Money
 FDA
 Federal Reserve
 Financial Advisors
 Financing
 Fintech
 first quarter earnings
 Forex
 Futures
 Gaming
 General
 Global
 Government
 Guidance
 Health Care
 Hedge Funds
 hemp bill
 hemp legalization
 hemp regulation
 Hot
 illegal cannabis farms
 Initiation
 Insider Trades
 Insurance
 Interview
 intoxicating hemp-derived products
 Intraday Update
 IPOs
 James Comer
 Large Cap
 Latin America
 Legal
 Long Ideas
 M&A
 Macro Economic Events
 Macro Notification
 Management
 marijuana
 Market Summary
 Market-Moving Exclusives
 Markets
 Media
 Mid Cap
 Movers
 Movers & Shakers
 New ETFs
 News
 Offerings
 Opinion
 Options
 Penny Stocks
 Personal Finance
 Politics
 Pre-Market Outlook
 Press Releases
 Previews
 Price Target
 Psychedelics
 Psychology
 Real Estate
 Regulations
 REIT
 Reiteration
 Rescheduling
 Restaurants
 Retail Sales
 Reviews
 Rumors
 SEC
 Sector ETFs
 Short Ideas
 Short Sellers
 Signals
 Small Business
 Small Cap
 Small Cap Analysis
 Social Media
 Specialty ETFs
 Sports
 Sports Betting
 Startups
 Stock Split
 Success Stories
 Taxes
 Tech
 Technicals
 THC
 Top Stories
 Topics
 Trading Ideas
 Travel
 UC Berkeley Cannabis Research Center
 unlicensed cannabis
 Upgrades
 WIIM

Join the Cannabis Revolution

Ready to access the most aggressive cannabis intelligence platform? Get started with IGNITE IT today.